Cargando…

Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach

BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with futur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunutsor, Setor K., Kieneker, Lyanne M., Burgess, Stephen, Bakker, Stephan J.L., Dullaart, Robin P.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721749/
https://www.ncbi.nlm.nih.gov/pubmed/29133521
http://dx.doi.org/10.1161/JAHA.117.006503
_version_ 1783284872289189888
author Kunutsor, Setor K.
Kieneker, Lyanne M.
Burgess, Stephen
Bakker, Stephan J.L.
Dullaart, Robin P.F.
author_facet Kunutsor, Setor K.
Kieneker, Lyanne M.
Burgess, Stephen
Bakker, Stephan J.L.
Dullaart, Robin P.F.
author_sort Kunutsor, Setor K.
collection PubMed
description BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with future hypertension risk and supplemented this with a Mendelian randomization approach to investigate any causal relevance to the association. METHODS AND RESULTS: Plasma total bilirubin levels were measured at baseline in the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective study of 3989 men and women without hypertension. Hazard ratios (95% confidence intervals) of total bilirubin with incident hypertension were assessed. New‐onset hypertension was recorded in 1206 participants during a median follow‐up of 10.7 years. Baseline total bilirubin was approximately log‐linearly associated with hypertension risk. Age‐ and sex‐adjusted hazard ratio for hypertension per 1‐SD increase in log(e) total bilirubin was 0.86 (0.81–0.92; P<0.001), which was attenuated to 0.94 (0.88–0.99; P=0.040) after further adjustment for established risk factors and other potential confounders. The association was marginally significant on further adjustment for high‐sensitivity C‐reactive protein (0.94; 0.88–1.00; P=0.067). A genetic variant at the UGT1A1*28 locus consistently shown to be strongly associated with circulating bilirubin levels—rs6742078—was not significantly associated with blood pressure or hypertension (P>0.05 for all), arguing against a strong causal association of circulating bilirubin with blood pressure. CONCLUSIONS: The weak and inverse association of circulating total bilirubin with future hypertension risk may be driven by biases such as unmeasured confounding and/or reverse causation. Further evaluation is warranted.
format Online
Article
Text
id pubmed-5721749
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57217492017-12-12 Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach Kunutsor, Setor K. Kieneker, Lyanne M. Burgess, Stephen Bakker, Stephan J.L. Dullaart, Robin P.F. J Am Heart Assoc Original Research BACKGROUND: Circulating total bilirubin is known to be inversely and independently associated with future risk of cardiovascular disease. However, the relationship of circulating total bilirubin with incident hypertension is uncertain. We aimed to assess the association of total bilirubin with future hypertension risk and supplemented this with a Mendelian randomization approach to investigate any causal relevance to the association. METHODS AND RESULTS: Plasma total bilirubin levels were measured at baseline in the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) prospective study of 3989 men and women without hypertension. Hazard ratios (95% confidence intervals) of total bilirubin with incident hypertension were assessed. New‐onset hypertension was recorded in 1206 participants during a median follow‐up of 10.7 years. Baseline total bilirubin was approximately log‐linearly associated with hypertension risk. Age‐ and sex‐adjusted hazard ratio for hypertension per 1‐SD increase in log(e) total bilirubin was 0.86 (0.81–0.92; P<0.001), which was attenuated to 0.94 (0.88–0.99; P=0.040) after further adjustment for established risk factors and other potential confounders. The association was marginally significant on further adjustment for high‐sensitivity C‐reactive protein (0.94; 0.88–1.00; P=0.067). A genetic variant at the UGT1A1*28 locus consistently shown to be strongly associated with circulating bilirubin levels—rs6742078—was not significantly associated with blood pressure or hypertension (P>0.05 for all), arguing against a strong causal association of circulating bilirubin with blood pressure. CONCLUSIONS: The weak and inverse association of circulating total bilirubin with future hypertension risk may be driven by biases such as unmeasured confounding and/or reverse causation. Further evaluation is warranted. John Wiley and Sons Inc. 2017-11-13 /pmc/articles/PMC5721749/ /pubmed/29133521 http://dx.doi.org/10.1161/JAHA.117.006503 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Kunutsor, Setor K.
Kieneker, Lyanne M.
Burgess, Stephen
Bakker, Stephan J.L.
Dullaart, Robin P.F.
Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
title Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
title_full Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
title_fullStr Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
title_full_unstemmed Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
title_short Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
title_sort circulating total bilirubin and future risk of hypertension in the general population: the prevention of renal and vascular end‐stage disease (prevend) prospective study and a mendelian randomization approach
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721749/
https://www.ncbi.nlm.nih.gov/pubmed/29133521
http://dx.doi.org/10.1161/JAHA.117.006503
work_keys_str_mv AT kunutsorsetork circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach
AT kienekerlyannem circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach
AT burgessstephen circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach
AT bakkerstephanjl circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach
AT dullaartrobinpf circulatingtotalbilirubinandfutureriskofhypertensioninthegeneralpopulationthepreventionofrenalandvascularendstagediseaseprevendprospectivestudyandamendelianrandomizationapproach